Answers are grounded in this paper and cite their sources.
Despite the efficacy of antipsychotics in treating schizophrenia and bipolar disorders over the last several decades, their molecular mechanisms of action turn out to be very complex and have not yet been fully elucidated. Recent thinking about a more personalized and endophenotype-specific diagnosing and treatment requires a more advanced genomic and proteomic approach and seems to be the next step in the treatment of mental disorders.
No takes yet. Share an insight, caveat, or question.
Paulina Rok-Bujko (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: